Traditional pacemakers have long been a vital treatment for individuals with slow heart rhythms (bradycardia). However, they come with challenges, including the need for leads (wires) and recovery from surgical incisions.
In November 2024, Dr Jeremy Chow and Dr Pipin Kojodjojo, Cardiac Electrophysiologists from Asian Heart & Vascular Centre successfully implanted the AVEIR leadless pacemaker for patients at Mount Elizabeth Hospital and Mount Elizabeth Novena Hospital.
Unlike conventional pacemakers, such leadless pacemakers eliminate the need for wires and surgical cuts, resulting in lower risk of complications.
“For decades, we’ve depended on pacemakers with leads to treat slow heart rhythms, but they have their own set of challenges. The AVEIR leadless pacemaker now provides a minimally invasive alternative that may provide longer-term outcomes,” shared Dr Chow.
Dr Kojodjojo added, “This advancement brings us closer to a future where pacemaker implants are simpler and durable. With the ability to synchronise both upper and lower heart chambers, easy retrieval for battery replacement, and an extended battery lifespan of up to 30 years for some patients, it presents another option for patients needing pacemakers.”
Since the first successful procedure, six more patients have received the leadless pacemaker at our IHH Healthcare Singapore hospitals - all without complications.
With a strong commitment to clinical excellence and patient experience, IHH continuously seeks innovative solutions to enhance patient care and elevate quality of life.
Related Stories
IHH Summer Medical Exchange Programme Inspires Future Healthcare Talent
IHH Malaysia Advances Dialogue on Value-Based Care and Collaboration at APHM Conference
Fortis Expands International Patient Access Through Strategic Partnership
IHH Singapore Achieves ANCC Pathway to Excellence® Designation With Distinction™
IHH Singapore Partners with ST Engineering to Transform Care Delivery
